Hip Arthroscopy
Depression, anxiety increased opioid use, health care costs after hip arthroscopy
Failed hip arthroscopy is manageable with nonoperative care, arthroplasty
Hip arthroscopy is a unique and novel specialty within the field of joint preservation. One of the most common indications for it, femoroacetabular impingement, was first coined in 1999. Initially, femoroacetabular impingement was commonly addressed with open surgical hip dislocation, a procedure described by Reinhold Ganz, MD, and colleagues in 2001, which was considered the gold standard for surgical treatment of femoroacetabular impingement for much of the following decade. Only in the last decade did hip arthroscopy become more commonly performed for this indication. However, the anatomic complexity of the hip joint, including the proximity of neurovascular structures and the relative inelasticity of the surrounding ligaments, yielded a significant learning curve. Inevitably, surgeons undertaking hip arthroscopies face a subset of patients with continued complaints, sometimes referred to as failed hip arthroscopy syndrome. The growing popularity of hip arthroscopy has necessitated the development of specialized referral centers, which must act as a resource to the surgeon facing a patient complaining of continued pain after primary hip arthroscopy.
Outcomes may decline after revision hip arthroscopy for borderline dysplasia
Low incidence of unplanned admission found after hip arthroscopy
High patient expectations before hip arthroscopy linked with improved outcomes
Psychological impairment linked to worse outcomes in FAI after hip arthroscopy
No difference seen in subjective results for hip arthroscopy after periacetabular osteotomy
Plain and liposomal bupivacaine resulted in similar pain scores after hip arthroscopy
Algorithm finds predictors of minimally clinically important differences after hip arthroscopy
BOSTON — Predictors of failure to achieve a minimally clinically important difference following hip arthroscopy include mental health, symptom duration length, non-intra-articular hip related pain and preoperative intra-articular injections, according to a presentation at the American Orthopaedic Society for Sports Medicine Annual Meeting.